Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Psychoneuroendocrinology|June 20, 2016
Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjectsEmil F Coccaro, Royce Lee, Jennifer R Fanning, et al.
Brain, Behavior, & Immunity - Health|April 13, 2026
Kynurenine pathway metabolites are increased in inflammatory depression and decrease with omega-3 treatmentJesper Lindahl, Gustav Söderberg Veibäck, Klara Suneson, et al.
Biological Psychiatry|March 10, 2009
Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severityDaniel Lindqvist, Shorena Janelidze, Peter Hagell, et al.
NPJ Schizophrenia|September 22, 2021
No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosisMaria Lee, Helena Fatouros-Bergman, Pontus Plavén-Sigray, et al.
Brain, Behavior, and Immunity|May 5, 2023
Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severityFeride Eren, Lilly Schwieler, Funda Orhan, et al.
Diabetes/Metabolism Research and Reviews|March 7, 2016
Direct effects of exercise on kynurenine metabolism in people with normal glucose tolerance or type 2 diabetesJonathan M Mudry, Petter S Alm, Sophie Erhardt, et al.
Brain, Behavior, and Immunity|July 21, 2015
Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptomsShahin Aeinehband, Philip Brenner, Sara Ståhl, et al.
Schizophrenia Research. Cognition|September 11, 2025
Cognition before and after psychosis onset: A naturalistic study of change, heterogeneity, and prognosisMaria Lee, Alexis E Cullen, Granville J Matheson, et al.
Psychiatry and Clinical Neurosciences|September 5, 2023
Disrupted-in-schizophrenia 1 protein aggregates in cerebrospinal fluid are elevated in patients with first-episode psychosisMarlene Pils, Julia Rutsch, Feride Eren, et al.
Journal of Neuroinflammation|March 2, 2016
Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patientsLilly Schwieler, Martin Samuelsson, Mark A Frye, et al.
Pageof 11